Parvovirus 4 infection and clinical outcome in high-risk populations
Parvovirus 4 (PARV4) is a DNA virus frequently associated with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections, but its clinical significance is unknown. We studied the prevalence of PARV4 antibodies in 2 cohorts of HIV- and HCV-infected individuals (n = 469) and the correl...
Main Authors: | Simmons, R, Sharp, C, Rohrbach, J, Kovari, H, Frangou, E, Simmonds, P, Irving, W, Rauch, A, Bowness, P, Klenerman, P, Swiss HIV Cohort Study |
---|---|
Other Authors: | Infectious Diseases Society of America |
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2012
|
Subjects: |
Similar Items
-
Parvovirus 4 infection and clinical outcome in high-risk populations.
by: Simmons, R, et al.
Published: (2012) -
High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo
by: Simmons, R, et al.
Published: (2011) -
Antibody-dependent cellular cytotoxicity responses and susceptibility influence HIV-1 mother-to-child transmission
by: Allison S. Thomas, et al.
Published: (2022-05-01) -
Gut-derived bacterial toxins impair memory CD4+ T cell mitochondrial function in HIV-1 infection
by: Brian Ferrari, et al.
Published: (2022-05-01) -
Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo
by: Shane D. Falcinelli, et al.
Published: (2022-04-01)